PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24826N0256IFOBT reagents — Polymedco Cancer Diagnostic Products LLC

Polymedco Cancer Diagnostic Products LLC holds $13.0M across 407 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C24825D0032. Recompete timing centers on the May 12, 2027 PoP end — agencies typically plan 12–18 months ahead.

248-Network Contract Office 8 (36C248)

Awarding office

Polymedco Cancer Diagnostic Products LLC

Recipient

May 12, 2027

PoP end

$133K

Obligated

$133K

Potential

334516

NAICS

6640

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C24826N0256

Also listed as36C248-26-N-0256

Also listed as36C24825D0032-36C24826N0256

Agency248-Network Contract Office 8 (36C248)

Awarding office248-Network Contract Office 8 (36C248)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentPolymedco Cancer Diagnostic Products LLC

CAGE6U4P6

UEIJYKKQ1NLJRX7

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640

Parent IDIQ / IDV36C24825D0032

Place of performanceCORTLANDT MANOR NY

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startMay 13, 2026

PoP end (current)May 12, 2027

Obligated$133K

Current value$133K

Potential value$133K

IFOBT REAGENTS is a federal award for 248-Network Contract Office 8 (36C248) held by Polymedco Cancer Diagnostic Products LLC. Estimated value $133K ($133K obligated). Current period of performance ends May 12, 2027. Place of performance: CORTLANDT MANOR NY.

Recompete timing

Public

● Expiring in 227 days

Current PoP ends May 12, 2027 (227 days remaining). Agencies typically plan 12–18 months ahead — at 7.5 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 36C24826N0256? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Polymedco Cancer Diagnostic Products LLC — $13.0M obligated across 407 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($13.0M) · all agencies · Top 3 shown (50%); remaining ~50% is other agencies.

Department of Veterans Affairs (VA)$5.8M · 45%Department of Defense (DOD)$546K · 4%Department of Health and Human Services (HHS)$143K · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C24E22F0001

FOBT ANALYZER & SUPPLIES

$504K

Sep 30, 2026

36C25726N0007

NTX FECAL OCCULT BLOOD TESTING CPRR

$165K

Sep 30, 2026

36C25726N0140

VISN 17 FECAL IMMUNOCHEMICAL TEST (FIT) KIT MAILING SERVICE - ORDERING PERIOD 2

$615K

Jan 14, 2027

36C24826N0438

CANCER SCREENING

$440K

Mar 31, 2027

36C24426N0755

MAILED FIT PROGRAM: PATIENT NAVIGATION SERVICES

$368K

Jun 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24826N0256?

36C24826N0256 (IFOBT reagents) is a 248-Network Contract Office 8 (36C248) award with a potential value of $133K, currently held by Polymedco Cancer Diagnostic Products LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C248-26-N-0256?

36C248-26-N-0256 is the dashed form of PIID 36C24826N0256 (IFOBT reagents), held by Polymedco Cancer Diagnostic Products LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24826N0256?

248-Network Contract Office 8 (36C248) awarded 36C24826N0256 to Polymedco Cancer Diagnostic Products LLC (potential $133K).

Who is the incumbent on 36C24826N0256?

Polymedco Cancer Diagnostic Products LLC is the incumbent with $13.0M across 407 related awards in SCOUT’s public footprint. The current period of performance ends May 12, 2027.

When does Polymedco Cancer Diagnostic Products LLC’s 36C24826N0256 come up for recompete?

SCOUT tracks a period-of-performance end of May 12, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C24826N0256? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action May 5, 2026